{"meta":{"query_hash":"5db7b903a306","filters":{"venue":"Journal of Immune Based Therapies and Vaccines"},"cohort_total":7,"direct_labels_cover":0,"predictions_cover":7,"exported":7,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5db7b903a306","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Immune+Based+Therapies+and+Vaccines"},"results":[{"id":"W1855748272","doi":"10.1186/1476-8518-4-1","title":"Cellular metabolism as a basis for immune privilege","year":2006,"lang":"en","type":"article","venue":"Journal of Immune Based Therapies and Vaccines","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Immune system; Immune privilege; Lipid metabolism; Hormone; Cell; Metabolism; Oxidative phosphorylation; Immunology; Cell biology; Medicine; Biology; Biochemistry","score_opus":0.009312431537668928,"score_gpt":0.2507508132480136,"score_spread":0.2414383817103447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1855748272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7759205,0.2167909,0.0015338948,0.0048476243,0.0004275225,0.0003251833,0.000007632393,0.000018548544,0.00012819594],"genre_scores_gemma":[0.98881197,0.0022836805,0.0053495113,0.00043728485,0.0012399183,0.000012822258,0.000009821675,0.000048319,0.0018066464],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985453,0.00004568312,0.0007877358,0.00014299901,0.00021113669,0.0002671385],"domain_scores_gemma":[0.99864465,0.00014989579,0.0004968628,0.00023881954,0.00037381428,0.000095969954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005244926,0.00023438477,0.0008088027,0.00024353377,0.0001286441,0.000038582282,0.0001214572,0.00009977192,0.00020799086],"category_scores_gemma":[0.000093297895,0.00015984019,0.00044285975,0.0001539773,0.000034164892,0.00017723959,0.000019431796,0.00017949933,0.000003616981],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026412297,0.0005765875,0.0013495106,0.00023127078,0.00079296395,0.0000872467,0.00044685838,0.000012125368,0.95881486,0.0042248094,0.0017787379,0.029043823],"study_design_scores_gemma":[0.012511528,0.0011449204,0.13595775,0.00036863738,0.0014200839,0.00047791234,0.00044627435,0.00010823286,0.268718,0.0020255055,0.5764648,0.0003564029],"about_ca_topic_score_codex":0.00010004261,"about_ca_topic_score_gemma":0.000002386229,"teacher_disagreement_score":0.69009686,"about_ca_system_score_codex":0.00001420541,"about_ca_system_score_gemma":0.00011793479,"threshold_uncertainty_score":0.6518094},"labels":[],"label_agreement":null},{"id":"W2012724561","doi":"10.1186/1476-8518-6-4","title":"CpG increases vaccine antigen-specific cell-mediated immunity when administered with hepatitis B vaccine in HIV infection","year":2008,"lang":"en","type":"article","venue":"Journal of Immune Based Therapies and Vaccines","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Immunology; Hepatitis B vaccine; HBsAg; Vaccination; Adjuvant; Immune system; CpG Oligodeoxynucleotide; Cellular immunity; Lymphoproliferative response; Antigen; Hepatitis B; Population; Virology; Immunity; Hepatitis B virus; Virus; Biology","score_opus":0.018009466657890386,"score_gpt":0.2388374094307557,"score_spread":0.22082794277286533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012724561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97236526,0.024800211,0.00022932999,0.0019770237,0.00013885784,0.0003529154,0.000015504562,0.00004019379,0.00008067659],"genre_scores_gemma":[0.9280957,0.06997329,0.0012279175,0.0003099106,0.00020509431,0.000017635695,0.000028644597,0.000052015774,0.0000898068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977173,0.0002110039,0.001138655,0.00023053959,0.00034403088,0.0003584298],"domain_scores_gemma":[0.99787235,0.0003294762,0.0007071644,0.00035009583,0.0005771189,0.00016378649],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048389586,0.00039236853,0.0011082622,0.0006280749,0.0002773131,0.000035314184,0.00013104577,0.00012059276,0.00038668784],"category_scores_gemma":[0.00014777665,0.00027386702,0.00017679871,0.00046238303,0.000046885445,0.00035346876,0.000054560885,0.0004832416,0.000006883919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038675603,0.0008284894,0.97938985,0.00010407784,0.00027435092,0.00044983305,0.0008974415,0.000009641831,0.011183655,0.0000056992494,0.0016375086,0.0013519102],"study_design_scores_gemma":[0.01292658,0.0027597586,0.9684725,0.00061782013,0.00007032319,0.0009176944,0.0001836203,0.00008054875,0.0044912444,0.000024026862,0.009175199,0.00028072976],"about_ca_topic_score_codex":0.00406221,"about_ca_topic_score_gemma":0.0017452462,"teacher_disagreement_score":0.045173083,"about_ca_system_score_codex":0.00010048616,"about_ca_system_score_gemma":0.00020141699,"threshold_uncertainty_score":0.99997133},"labels":[],"label_agreement":null},{"id":"W2104152758","doi":"10.1186/1476-8518-6-3","title":"Immunostimulatory effects of three classes of CpG oligodeoxynucleotides on PBMC from HCV chronic carriers","year":2008,"lang":"en","type":"article","venue":"Journal of Immune Based Therapies and Vaccines","topic":"Hepatitis C virus research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Honeywell (Canada); Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; CpG Oligodeoxynucleotide; Virology; Immunology; Peripheral blood mononuclear cell; Chronic hepatitis; Virus; Computational biology; Biology; Genetics; Gene","score_opus":0.01831191028238305,"score_gpt":0.27172572196454653,"score_spread":0.2534138116821635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104152758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9539605,0.044938907,0.00010055825,0.00047370454,0.00018664057,0.0002301066,0.000012138864,0.000008861786,0.00008861039],"genre_scores_gemma":[0.9916832,0.0075436896,0.00042450937,0.000103748716,0.00017426479,0.0000038120504,0.0000030423469,0.00003529007,0.000028436165],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982603,0.00011739165,0.00078820926,0.00013540791,0.00047026906,0.00022841146],"domain_scores_gemma":[0.99767715,0.0009032417,0.0005383932,0.00034544227,0.0004212857,0.00011447168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030329666,0.00020849373,0.0008645536,0.00032751996,0.00009001823,0.000009318528,0.0001848229,0.00010512481,0.00018494771],"category_scores_gemma":[0.00037038134,0.00014710905,0.0003006684,0.00018847513,0.0001612093,0.00013384628,0.000035467394,0.0003399161,0.0000019069206],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004381199,0.0005567425,0.3286574,0.0009205424,0.0017770546,0.00024061296,0.00084076484,0.0002290889,0.62695587,0.0000827175,0.0005594846,0.034798544],"study_design_scores_gemma":[0.0074897795,0.004609451,0.7798983,0.0015846957,0.00015792371,0.000029622955,0.00011566192,0.00044176835,0.20399463,0.00012863343,0.0014029273,0.00014660512],"about_ca_topic_score_codex":0.00047074034,"about_ca_topic_score_gemma":0.000030455463,"teacher_disagreement_score":0.4512409,"about_ca_system_score_codex":0.00007521487,"about_ca_system_score_gemma":0.00042432238,"threshold_uncertainty_score":0.5998933},"labels":[],"label_agreement":null},{"id":"W2118464379","doi":"10.1186/1476-8518-4-7","title":"Longitudinal changes in HIV-specific IFN-γ secretion in subjects who received Remune™ vaccination prior to treatment interruption","year":2006,"lang":"en","type":"article","venue":"Journal of Immune Based Therapies and Vaccines","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"HIV Legal Network; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"Canadian Foundation for AIDS Research","keywords":"Medicine; Viremia; ELISPOT; Immunology; Viral load; Vaccination; Drug holiday; Immunity; Population; Virology; Immune system; Internal medicine; Human immunodeficiency virus (HIV); T cell","score_opus":0.023314137932389425,"score_gpt":0.2795082185347637,"score_spread":0.2561940806023743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118464379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755513,0.019579858,0.00013083727,0.0041633593,0.0001776835,0.00033101195,0.000010905688,0.000008913834,0.000046110996],"genre_scores_gemma":[0.99574226,0.0034636154,0.00015125216,0.000022269576,0.00006413691,0.000026281006,0.00006457771,0.00001280143,0.0004528272],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987868,0.00022864228,0.00047907667,0.0001782089,0.000055990586,0.00027130407],"domain_scores_gemma":[0.99939716,0.00011118969,0.00021743716,0.00012831781,0.00012109523,0.000024793057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003893491,0.00018735843,0.0003902199,0.00065118,0.00008461408,0.00003522293,0.00009458651,0.00010599515,0.00024473688],"category_scores_gemma":[0.000023083112,0.00013412308,0.00008146231,0.00024053991,0.000018462215,0.0001414446,0.000018425164,0.00016374927,0.000019727573],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009046132,0.0016446039,0.2767843,0.000055172593,0.0002692816,0.00012495577,0.0026702182,0.00022343169,0.49281675,0.00014742793,0.00069138536,0.21552634],"study_design_scores_gemma":[0.00781416,0.002130441,0.95289004,0.00022986617,0.000015891022,0.000060496688,0.0005155977,0.00001905478,0.027576765,0.00009122278,0.008524217,0.00013224351],"about_ca_topic_score_codex":0.00046203344,"about_ca_topic_score_gemma":0.0028059708,"teacher_disagreement_score":0.67610574,"about_ca_system_score_codex":0.0002448925,"about_ca_system_score_gemma":0.00004474042,"threshold_uncertainty_score":0.54693806},"labels":[],"label_agreement":null},{"id":"W2142025413","doi":"10.1186/1476-8518-8-4","title":"PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens","year":2010,"lang":"en","type":"article","venue":"Journal of Immune Based Therapies and Vaccines","topic":"Advanced Drug Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Saskatchewan","funders":"Krembil Foundation; Saskatchewan Health Research Foundation; Bill and Melinda Gates Foundation","keywords":"Adjuvant; Nasal administration; Immune system; Immunology; Medicine; Antigen; Immunization","score_opus":0.03500577706539187,"score_gpt":0.36762756564754484,"score_spread":0.33262178858215297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142025413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97702837,0.020327862,0.00038978326,0.0006151906,0.0013338304,0.00024915076,0.000010540991,0.000025919104,0.000019370913],"genre_scores_gemma":[0.9971338,0.0016250703,0.00059286196,0.00031170587,0.00019311256,0.0000107412,0.0000048714455,0.00003614891,0.000091686314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978703,0.00048525052,0.00094355707,0.00018623933,0.00018495189,0.0003296819],"domain_scores_gemma":[0.9979295,0.00081341784,0.00074730074,0.00019335927,0.00022293132,0.00009349783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009934257,0.00031259857,0.00061813014,0.00033682387,0.00026073566,0.000057703484,0.00030047176,0.00020621534,0.00012546558],"category_scores_gemma":[0.00014541486,0.00021789392,0.00016239,0.00026363228,0.000084448926,0.0004728311,0.00004720823,0.00092892523,0.0000027332921],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035715662,0.00026171326,0.09318223,0.00003548824,0.00032435165,0.000053738106,0.0013265365,0.00040130242,0.8942629,0.000033833596,0.000012687689,0.0065336595],"study_design_scores_gemma":[0.009005428,0.0008462591,0.33347028,0.00029162242,0.00020353618,0.00016218581,0.0019946117,0.0012115126,0.641671,0.00010466377,0.010538899,0.00049998326],"about_ca_topic_score_codex":0.00007953448,"about_ca_topic_score_gemma":0.00017605771,"teacher_disagreement_score":0.25259188,"about_ca_system_score_codex":0.000033110256,"about_ca_system_score_gemma":0.00009612253,"threshold_uncertainty_score":0.8885456},"labels":[],"label_agreement":null},{"id":"W2165217477","doi":"10.1186/1476-8518-1-3","title":"A Canadian national survey of attitudes and knowledge regarding preventive vaccines","year":2003,"lang":"en","type":"article","venue":"Journal of Immune Based Therapies and Vaccines","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Toronto General Hospital; University of Toronto; University Health Network; Ontario Institute for Cancer Research; York University","funders":"","keywords":"Medicine; Telephone survey; Public health; Vaccine safety; Public support; Family medicine; Environmental health; Public relations; Immunization; Nursing; Immunology; Political science; Business","score_opus":0.02702331419940931,"score_gpt":0.31121915042345855,"score_spread":0.28419583622404926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165217477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95959586,0.037441857,0.000044453333,0.0011650203,0.00021623335,0.00010840905,0.000009104042,0.0000043147757,0.0014147697],"genre_scores_gemma":[0.9966148,0.002604468,0.0002481796,0.000058665937,0.00009509106,0.0000013448947,0.0000011534346,0.000009164581,0.00036711644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987504,0.00038000674,0.00041591068,0.00009823727,0.0001703951,0.00018503192],"domain_scores_gemma":[0.99812514,0.00042400957,0.00031835117,0.00006505692,0.00094916666,0.0001182682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022465019,0.00011337167,0.00031706077,0.0002555987,0.00032105803,0.000065681124,0.00012217856,0.00006416854,0.00014954142],"category_scores_gemma":[0.0007514488,0.00009023561,0.00008344107,0.00025749594,0.000015395379,0.00030719076,0.000011113937,0.00010293774,4.953218e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013369821,0.00011166683,0.98462117,0.00006622634,0.00024452587,0.000005266834,0.004119595,0.000008196483,0.00066018157,0.0053324644,0.0012906399,0.003406346],"study_design_scores_gemma":[0.0012341009,0.0001453,0.9871194,0.00016407338,0.00002783236,0.000011171172,0.0012382962,0.000009084065,0.0003018751,0.0012208164,0.008400768,0.0001272826],"about_ca_topic_score_codex":0.024093201,"about_ca_topic_score_gemma":0.16737586,"teacher_disagreement_score":0.14328265,"about_ca_system_score_codex":0.0000664307,"about_ca_system_score_gemma":0.0009714149,"threshold_uncertainty_score":0.9824054},"labels":[],"label_agreement":null},{"id":"W2171927847","doi":"10.1186/1476-8518-3-3","title":"Granulocyte-macrophage colony-stimulating factor as an immune-based therapy in HIV infection","year":2005,"lang":"en","type":"article","venue":"Journal of Immune Based Therapies and Vaccines","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Immunology; Immune system; Immunity; Disease; Intensive care medicine; Antiretroviral therapy; Human immunodeficiency virus (HIV); Viral load; Internal medicine","score_opus":0.01490792995513445,"score_gpt":0.28715157999969426,"score_spread":0.2722436500445598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171927847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97309774,0.025050795,0.0001355501,0.001205789,0.00017463783,0.00026232703,0.000017936522,0.000022758737,0.000032464533],"genre_scores_gemma":[0.99755836,0.001666117,0.0002945866,0.00015964214,0.000073930285,0.000012926978,0.00004158657,0.000024046763,0.0001688081],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983558,0.00037714117,0.00065261306,0.00017889764,0.0000776171,0.00035794324],"domain_scores_gemma":[0.99896497,0.0002608921,0.0003444085,0.00020701978,0.00017118691,0.00005152304],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004939448,0.00024831988,0.00048163757,0.00035169607,0.0002414124,0.000056413468,0.00015718213,0.00016488213,0.00094155513],"category_scores_gemma":[0.00006350845,0.00017333102,0.00018897883,0.00017377893,0.000063574924,0.00030468454,0.000018535688,0.00041047018,0.00004655393],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005354929,0.0013495337,0.19240394,0.000028466528,0.00044631583,0.00004983695,0.0009339768,0.0008906214,0.65875953,0.00003164564,0.000082219114,0.13966896],"study_design_scores_gemma":[0.023678675,0.0053939885,0.7911448,0.00015941153,0.00003347306,0.00011741001,0.00022081372,0.00039725172,0.16436572,0.00006585202,0.014101084,0.00032155582],"about_ca_topic_score_codex":0.00043280446,"about_ca_topic_score_gemma":0.000101438076,"teacher_disagreement_score":0.5987408,"about_ca_system_score_codex":0.00008006736,"about_ca_system_score_gemma":0.00014073424,"threshold_uncertainty_score":0.99997175},"labels":[],"label_agreement":null}]}